Live feed18:00:08·18mINSIDERFilingvia QuantisnowEVP, Clinical Development Xu Cong Claire converted options into 9,382 units of Ordinary Shares and sold $2,593 worth of Ordinary Shares (3,282 units at $0.79), increasing direct ownership by 2% to 304,201 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.NBP· NovaBridge BiosciencesHealth CareOriginal source
